The value of medicines dispensed to patients in Romania reached the wholesale level of RON 2.83 billion (EUR 637 million) in the second quarter of 2015, decreasing by 4.1 percent as compared to the second quarter of 2014, according to the results of Cegedim’s Pharma & Hospital Report study.
“Market decline from the second quarter was mainly due to the malfunctions caused by the process of prices cuts, including all the associated shortcomings for patients, pharmacies and wholesalers. As regards the year 2015, we maintain our forecast of market decline by 2.8 percent in RON, but we are also expecting other developments due to availability and sustainability problems in the healthcare system,” said Petru Craciun, Cegedim’s general manager.
The prescription medicines (Rx) from pharmacies reached RON 1.92 billion in Q2, decreasing by 10.4 percent. The OTC medicines summed up to RON 0.53 billion, increasing by 14.5 percent, and the hospital segment accounted for RON 0.37 billion, up by 10.5 percent as compared to the second quarter of the previous year.
In the last 6 months (January – June 2015), the total market value reached RON 6.09 billion (EUR 1.37 billion), up by 3.3 percent as compared to the same period of the previous year (January – June 2014). By segments, the growth rates in RON were of -1.9 percent for Rx in pharmacies, 21.3 percent for OTC and 11.0 percent for hospitals.
Regarding the evolution of the main therapeutic groups, the past 12 months show an increase above the market average in terms of volume in the case of medicines for respiratory system (16.0 percent), blood and blood forming organs (10.8 percent), antineoplastic and immunomodulators (9.4 percent) and the digestive system and metabolism (9.1 percent); in terms of values, the increase of medicines for the respiratory system (19.4%), the digestive system and metabolism (11.6 percent), blood and blood forming organs (11.0 percent) and for systemic antiinfectives (9.7 percent) is higher than the other groups, according to the Cegedim report.